Category: Philips Healthcare
The FDA warns again of issues that may prevent Philips' HeartStart automated defibrillators from delivering emergency therapy.
MASSDEVICE ON CALL — Medtech giant Philips Healthcare (NYSE:PHG) got renewed attention for its troubled HeartStart automated external defibrillators after the FDA this week issued a new warning letter over potentially faulty electrical components.
Philips and Sectra renew their long-standing agreement for another 7 years, allowing Philips to continue to support Sectra's PACS systems.
A federal judge shoots down bids by Philips and Zoll to dismiss a patent infringement case over automated external defibrillator technology.
A small, 8-patient trial of heart surgery uses 3d holographic images that can be manipulated by surgeons during the procedure.
MASSDEVICE ON CALL — A system that can generate holographic 3D images of the heart that surgeons can manipulate during procedures was used in a small, 8-patient trial in Israel.
Philips (NYSE:PHG) and RealView Imaging developed the live 3D holographic imaging using X-ray and ultrasound imaging. The holographs can be seen "floating in free space" by the surgeons, who can use them to guide the surgery.
Philips and Infraredx ink a resale deal for Infraredx's TVC imaging system sales alongside Philips' Allura X-ray devices.
Profits for Philips Healthcare rose nearly 8% during the 3rd quarter, despite a sales slump of nearly the same proportions.
Philips Healthcare (NYSE:PHG) managed to boost its profits by nearly 8% during the 3rd quarter, despite posting a sales slump of more than 7%.
Sir John Buchanan, the chairman of Smith & Nephew, is reportedly getting ready to step down from the medical device company's board of directors.